Co-morbidity in psoriasis: mechanisms and implications for treatment

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Co-morbidity in psoriasis : mechanisms and implications for treatment. / Lønnberg, Ann Sophie; Skov, Lone.

I: Expert Review of Clinical Immunology, Bind 13, Nr. 1, 2017, s. 27-34.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Lønnberg, AS & Skov, L 2017, 'Co-morbidity in psoriasis: mechanisms and implications for treatment', Expert Review of Clinical Immunology, bind 13, nr. 1, s. 27-34. https://doi.org/10.1080/1744666X.2016.1213631

APA

Lønnberg, A. S., & Skov, L. (2017). Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Review of Clinical Immunology, 13(1), 27-34. https://doi.org/10.1080/1744666X.2016.1213631

Vancouver

Lønnberg AS, Skov L. Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Review of Clinical Immunology. 2017;13(1):27-34. https://doi.org/10.1080/1744666X.2016.1213631

Author

Lønnberg, Ann Sophie ; Skov, Lone. / Co-morbidity in psoriasis : mechanisms and implications for treatment. I: Expert Review of Clinical Immunology. 2017 ; Bind 13, Nr. 1. s. 27-34.

Bibtex

@article{35cd470c63374bdeb9ee9a64f97e58f7,
title = "Co-morbidity in psoriasis: mechanisms and implications for treatment",
abstract = "INTRODUCTION: Psoriasis is a common, chronic, immune-mediated inflammatory disorder. The disease is associated with several co-morbidities including cardiovascular disease, metabolic syndrome, and psychiatric disorders. It is important to identify and treat these co-morbidities because they have a strongly negative effect on the overall health of patients with psoriasis. Unfortunately, these co-morbidities are often overlooked and/or left untreated. Therefore, the aim of this review is to discuss the mechanisms of how co-morbidities are associated with psoriasis as well as implications for the clinic to be able to recognize such co-morbidities. Areas covered: This is a review of studies investigating and discussing co-morbidities of psoriasis and screening. Literature was retrieved by searching on the PubMed database using individual and combined search terms related to relevant co-morbidities. Expert commentary: Effective management of psoriasis involves targeting of both psoriasis and co-morbidities.",
keywords = "Journal Article",
author = "L{\o}nnberg, {Ann Sophie} and Lone Skov",
year = "2017",
doi = "10.1080/1744666X.2016.1213631",
language = "English",
volume = "13",
pages = "27--34",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Co-morbidity in psoriasis

T2 - mechanisms and implications for treatment

AU - Lønnberg, Ann Sophie

AU - Skov, Lone

PY - 2017

Y1 - 2017

N2 - INTRODUCTION: Psoriasis is a common, chronic, immune-mediated inflammatory disorder. The disease is associated with several co-morbidities including cardiovascular disease, metabolic syndrome, and psychiatric disorders. It is important to identify and treat these co-morbidities because they have a strongly negative effect on the overall health of patients with psoriasis. Unfortunately, these co-morbidities are often overlooked and/or left untreated. Therefore, the aim of this review is to discuss the mechanisms of how co-morbidities are associated with psoriasis as well as implications for the clinic to be able to recognize such co-morbidities. Areas covered: This is a review of studies investigating and discussing co-morbidities of psoriasis and screening. Literature was retrieved by searching on the PubMed database using individual and combined search terms related to relevant co-morbidities. Expert commentary: Effective management of psoriasis involves targeting of both psoriasis and co-morbidities.

AB - INTRODUCTION: Psoriasis is a common, chronic, immune-mediated inflammatory disorder. The disease is associated with several co-morbidities including cardiovascular disease, metabolic syndrome, and psychiatric disorders. It is important to identify and treat these co-morbidities because they have a strongly negative effect on the overall health of patients with psoriasis. Unfortunately, these co-morbidities are often overlooked and/or left untreated. Therefore, the aim of this review is to discuss the mechanisms of how co-morbidities are associated with psoriasis as well as implications for the clinic to be able to recognize such co-morbidities. Areas covered: This is a review of studies investigating and discussing co-morbidities of psoriasis and screening. Literature was retrieved by searching on the PubMed database using individual and combined search terms related to relevant co-morbidities. Expert commentary: Effective management of psoriasis involves targeting of both psoriasis and co-morbidities.

KW - Journal Article

U2 - 10.1080/1744666X.2016.1213631

DO - 10.1080/1744666X.2016.1213631

M3 - Review

C2 - 27426230

VL - 13

SP - 27

EP - 34

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 1

ER -

ID: 176702067